These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22370156)

  • 1. Psychological characteristics of early remitters in patients with panic disorder.
    Park HJ; Kim EJ; Ku JI; Woo JM; Lee SH; Chung SK; Lee SY; Kim YR; Kang EH; Lee JH; Kim JH; Yu BH
    Psychiatry Res; 2012 May; 197(3):237-41. PubMed ID: 22370156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a mindfulness-based cognitive therapy program as an adjunct to pharmacotherapy in patients with panic disorder.
    Kim B; Lee SH; Kim YW; Choi TK; Yook K; Suh SY; Cho SJ; Yook KH
    J Anxiety Disord; 2010 Aug; 24(6):590-5. PubMed ID: 20427148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panic Disorder Severity Scale: reliability and validity of the Turkish version.
    Monkul ES; Tural U; Onur E; Fidaner H; Alkin T; Shear MK
    Depress Anxiety; 2004; 20(1):8-16. PubMed ID: 15368591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive factors in panic disorder, agoraphobic avoidance and agoraphobia.
    Berle D; Starcevic V; Hannan A; Milicevic D; Lamplugh C; Fenech P
    Behav Res Ther; 2008 Feb; 46(2):282-91. PubMed ID: 18191103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression does not affect the treatment outcome of CBT for panic and agoraphobia: results from a multicenter randomized trial.
    Emmrich A; Beesdo-Baum K; Gloster AT; Knappe S; Höfler M; Arolt V; Deckert J; Gerlach AL; Hamm A; Kircher T; Lang T; Richter J; Ströhle A; Zwanzger P; Wittchen HU
    Psychother Psychosom; 2012; 81(3):161-72. PubMed ID: 22399019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
    Spiegel DA; Saeed SA; Bruce TJ
    J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating effective treatment factors in brief cognitive behavioral therapy for panic disorder.
    Lim JA; Lee YI; Jang JH; Choi SH
    Medicine (Baltimore); 2018 Sep; 97(38):e12422. PubMed ID: 30235717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anxiety sensitivity in social phobia: comparison between social phobics with and without panic attacks.
    Scott EL; Heimberg RG; Jack MS
    Depress Anxiety; 2000; 12(4):189-92. PubMed ID: 11195754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heightened embarrassability discriminates between panic disorder patients with and without agoraphobia.
    Swoboda H; Demal U; Krautgartner M; Amering M
    J Behav Ther Exp Psychiatry; 2003; 34(3-4):195-204. PubMed ID: 14972667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The structure of lifetime panic-agoraphobic spectrum.
    Rucci P; Miniati M; Oppo A; Mula M; Calugi S; Frank E; Shear MK; Mauri M; Pini S; Cassano GB
    J Psychiatr Res; 2009 Jan; 43(4):366-79. PubMed ID: 18499126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panic disorder with and without agoraphobia: comorbidity within a half-year of the onset of panic disorder.
    Kikuchi M; Komuro R; Oka H; Kidani T; Hanaoka A; Koshino Y
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):639-43. PubMed ID: 16401237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
    Carter CS; Fawcett J; Hertzman M; Papp LA; Jones W; Patterson WM; Swinson RP; Weise CC; Maddock RJ; Denahan AQ
    J Clin Psychiatry; 1995 May; 56(5):202-10. PubMed ID: 7737960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The scores of Hamilton depression, anxiety, and panic agoraphobia rating scales in patients with acute coronary syndrome.
    Vural M; Acer M; Akbaş B
    Anadolu Kardiyol Derg; 2008 Feb; 8(1):43-7. PubMed ID: 18258533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tryptophan hydroxylase and serotonin transporter gene polymorphism does not affect the diagnosis, clinical features and treatment outcome of panic disorder in the Korean population.
    Kim W; Choi YH; Yoon KS; Cho DY; Pae CU; Woo JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1413-8. PubMed ID: 16822601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission?
    Zimmerman M; Martinez JA; Attiullah N; Friedman M; Toba C; Boerescu DA; Rahgeb M
    J Clin Psychiatry; 2012 Jun; 73(6):790-5. PubMed ID: 22569085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the self-report version of the Panic Disorder Severity Scale in Korea.
    Lee EH; Kim JH; Yu BH
    Depress Anxiety; 2009; 26(8):E120-3. PubMed ID: 19373866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panic disorder and dissociation - comparison with healthy controls.
    Pastucha P; Prasko J; Grambal A; Latalova K; Sigmundova Z; Sykorova T; Tichackova A
    Neuro Endocrinol Lett; 2009; 30(6):774-8. PubMed ID: 20038926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?
    Bandelow B; Baldwin DS; Dolberg OT; Andersen HF; Stein DJ
    J Clin Psychiatry; 2006 Sep; 67(9):1428-34. PubMed ID: 17017830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychological treatment for panic disorder with agoraphobia: a randomized controlled trial to examine the role of therapist-guided exposure in situ in CBT.
    Gloster AT; Wittchen HU; Einsle F; Lang T; Helbig-Lang S; Fydrich T; Fehm L; Hamm AO; Richter J; Alpers GW; Gerlach AL; Ströhle A; Kircher T; Deckert J; Zwanzger P; Höfler M; Arolt V
    J Consult Clin Psychol; 2011 Jun; 79(3):406-20. PubMed ID: 21534651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.